composto composição farmacêutica,método para inibir ativi dades de ck1, método para inibir atividade de ck2 e uso de um composto ou uma composição farmacêutica
Disclosed are compounds, pharmaceutical compositions containing those compounds, and uses of the compounds and compositions as modulators of casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), Pim1, Pim2, Pim3, the TGF pathway, the Wnt pathway, the JAK/STAT pathway, and/or the mTOR pathway. Uses ar...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Portuguese |
Published |
07.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are compounds, pharmaceutical compositions containing those compounds, and uses of the compounds and compositions as modulators of casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), Pim1, Pim2, Pim3, the TGF pathway, the Wnt pathway, the JAK/STAT pathway, and/or the mTOR pathway. Uses are also disclosed for the treatment or prevention of a range of therapeutic indications due at least in part to aberrant physiological activity of casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), Pim1, Pim2, Pim3, the TGF pathway, the Wnt pathway, the JAK/STAT pathway, and/or the mTOR pathway. |
---|---|
Bibliography: | Application Number: BR20121115248 |